Invasive aspergillosis: current and future challenges in diagnosis and therapy
Open Access
- 1 January 2004
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 10 (1), 2-4
- https://doi.org/10.1111/j.1469-0691.2004.00809.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Identification of the Cytochrome P450 Enzymes Involved in theN-Oxidation of VoriconazoleDrug Metabolism and Disposition, 2003
- Voriconazole: A New Triazole Antifungal AgentClinical Infectious Diseases, 2003
- Multidrug Resistance inAspergillus fumigatusNew England Journal of Medicine, 2002
- Voriconazole versus Amphotericin B for Invasive AspergillosisNew England Journal of Medicine, 2002
- Itraconazole Preexposure Attenuates the Efficacy of Subsequent Amphotericin B Therapy in a Murine Model of Acute Invasive Pulmonary AspergillosisAntimicrobial Agents and Chemotherapy, 2002
- Voriconazole versus Amphotericin B for Primary Therapy of Invasive AspergillosisNew England Journal of Medicine, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002
- A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592)Journal of Antimicrobial Chemotherapy, 2000
- In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungiJournal of Antimicrobial Chemotherapy, 1998
- Therapeutic Outcome in Invasive AspergillosisClinical Infectious Diseases, 1996